Accelerated Hypofractionated Radiation Therapy for glioblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Mar 2023: Trial registered, NCT05781321
  2. 23 Mar 2023: Trial started, NCT05781321

The trials

NCT05781321: Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

State
Under way
Phase
Phase 2
People
170 planned
Started
23 Mar 2023
Primary completion
30 Nov 2026
Arms
Arm A (short course RT)
Results
None posted
  1. 23 Mar 2023: Trial registered
  2. 23 Mar 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.